| CXSL1800084 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-08-01 | 杭州尚健生物技术有限公司 | Hangzhou Shangjian Biotechnology Co Ltd | Certificate Issued | 2018-10-15 | view |
| CXSB1900009 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products | Supplementary Application | 2019-04-30 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2019-06-03 | view |
| CXSL2000032 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-02-22 | 上海昀怡健康科技发展有限公司 | Shanghai Yunyi Health Technology Development Co Ltd | In Review | 2020-02-21 | view |
| CXSL2000352 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-12-14 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | In Review | 2020-12-10 | view |
| CXSL2000351 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-12-14 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | In Review | 2020-12-10 | view |
| CXSL2101103 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-05-31 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2101138 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-06-18 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2101280 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-08-27 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2101307 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(3.3) | New Drug Application | 2021-09-03 | | Dongguan HEC Biopharmaceutical R&D Co Ltd | | | view |
| CXSL2101378 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-10-21 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2101380 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-10-26 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2101525 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2021-12-28 | | Beijing Dongfang Biotech Co Ltd | | | view |
| CXSL2200347 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2022-08-01 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2200551 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2022-11-01 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2200560 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2022-11-07 | | Shanghai Yunyi Health Technology Development Co Ltd | | | view |
| CXSL2200576 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2022-11-16 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2300061 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2023-01-28 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2300389 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2023-06-02 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2300414 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2023-06-14 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
| CXSL2300482 | 重组抗PD-1全人源单克隆抗体注射液 | Recombinant anti-PD-1 humanized monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2023-07-15 | | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | | | view |
